GE HealthCare Technologies Inc. $GEHC Shares Bought by Whittier Trust Co.

Whittier Trust Co. lifted its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHCFree Report) by 2.0% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 132,597 shares of the company’s stock after purchasing an additional 2,550 shares during the period. Whittier Trust Co.’s holdings in GE HealthCare Technologies were worth $9,820,000 as of its most recent SEC filing.

Other hedge funds have also modified their holdings of the company. Bessemer Group Inc. increased its stake in shares of GE HealthCare Technologies by 24.3% during the 1st quarter. Bessemer Group Inc. now owns 6,671 shares of the company’s stock worth $538,000 after purchasing an additional 1,306 shares in the last quarter. Flagship Harbor Advisors LLC increased its stake in shares of GE HealthCare Technologies by 17.4% during the 1st quarter. Flagship Harbor Advisors LLC now owns 3,443 shares of the company’s stock worth $278,000 after purchasing an additional 511 shares in the last quarter. Lineweaver Wealth Advisors LLC purchased a new position in shares of GE HealthCare Technologies during the 2nd quarter worth approximately $592,000. Wealth Enhancement Advisory Services LLC increased its stake in shares of GE HealthCare Technologies by 23.8% during the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 50,859 shares of the company’s stock worth $4,105,000 after purchasing an additional 9,769 shares in the last quarter. Finally, Exome Asset Management LLC purchased a new position in shares of GE HealthCare Technologies during the 1st quarter worth approximately $2,050,000. 82.06% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of analysts recently issued reports on the stock. Weiss Ratings restated a “hold (c+)” rating on shares of GE HealthCare Technologies in a research report on Tuesday, October 14th. Wall Street Zen lowered shares of GE HealthCare Technologies from a “buy” rating to a “hold” rating in a research report on Saturday, September 20th. Morgan Stanley set a $74.00 target price on shares of GE HealthCare Technologies in a research report on Thursday, September 18th. BTIG Research raised their target price on shares of GE HealthCare Technologies from $87.00 to $89.00 and gave the stock a “buy” rating in a research report on Monday, October 13th. Finally, Zacks Research lowered shares of GE HealthCare Technologies from a “strong-buy” rating to a “hold” rating in a research report on Monday, September 29th. Six investment analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, GE HealthCare Technologies presently has an average rating of “Moderate Buy” and an average price target of $85.20.

Check Out Our Latest Stock Analysis on GEHC

GE HealthCare Technologies Stock Up 0.8%

Shares of GEHC opened at $76.10 on Wednesday. The firm has a market cap of $34.74 billion, a PE ratio of 15.59, a price-to-earnings-growth ratio of 2.88 and a beta of 1.13. The company’s fifty day moving average is $74.60 and its two-hundred day moving average is $72.16. GE HealthCare Technologies Inc. has a fifty-two week low of $57.65 and a fifty-two week high of $94.80. The company has a quick ratio of 0.93, a current ratio of 1.16 and a debt-to-equity ratio of 0.85.

GE HealthCare Technologies (NASDAQ:GEHCGet Free Report) last announced its quarterly earnings results on Wednesday, July 30th. The company reported $1.06 earnings per share for the quarter, beating analysts’ consensus estimates of $0.91 by $0.15. The company had revenue of $5 billion for the quarter, compared to analyst estimates of $4.96 billion. GE HealthCare Technologies had a net margin of 11.22% and a return on equity of 23.93%. GE HealthCare Technologies’s revenue for the quarter was up 3.5% on a year-over-year basis. During the same quarter last year, the business earned $1.00 EPS. GE HealthCare Technologies has set its FY 2025 guidance at 4.430-4.630 EPS. Analysts forecast that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.

GE HealthCare Technologies Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, November 14th. Shareholders of record on Friday, October 24th will be issued a $0.035 dividend. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.2%. The ex-dividend date is Friday, October 24th. GE HealthCare Technologies’s dividend payout ratio (DPR) is 2.87%.

GE HealthCare Technologies Company Profile

(Free Report)

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.

Featured Articles

Want to see what other hedge funds are holding GEHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for GE HealthCare Technologies Inc. (NASDAQ:GEHCFree Report).

Institutional Ownership by Quarter for GE HealthCare Technologies (NASDAQ:GEHC)

Receive News & Ratings for GE HealthCare Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GE HealthCare Technologies and related companies with MarketBeat.com's FREE daily email newsletter.